"I Thought I Was Just Tired"—Don't Ignore the Signals Your Eyelids Are Sending [Health Check]

[Financial News] Symptoms that begin with ptosis and diplopia may progress to generalized muscle weakness or breathing difficulties if they are dismissed as simple fatigue.
A Konkuk University Medical Center research team analyzed 138 patients with myasthenia gravis and found clear differences between ocular and generalized forms in antibody positivity rates and thymoma detection rates, among other measures.
Myasthenia gravis is an autoimmune disease in which the immune system interferes with signal transmission between nerves and muscles, causing muscle fatigue and weakness. The muscles that raise the eyelids or move the eyes are particularly likely to be affected first, so ptosis and diplopia are often the initial symptoms. When symptoms remain confined to the eyes, the condition is called ocular myasthenia gravis. When it spreads to the face, neck, limbs, and the muscles involved in swallowing and breathing, it is called generalized myasthenia gravis.
A team led by Shin Hyun-Jin of the Department of Ophthalmology and Jeeyoung Oh of the Department of Neurology at Konkuk University Medical Center published a study in an international medical journal comparing the clinical features and test results of 138 Korean patients with myasthenia gravis—98 with ocular disease and 40 with generalized disease.
The acetylcholine receptor antibody positivity rate was 92.5% among patients with generalized disease, compared with 36.3% among those with ocular disease. Abnormal results on the repetitive nerve stimulation test, which repeatedly stimulates nerves to assess muscle responses, were also much more common in the generalized group, at 90.0%, than in the ocular group, at 23.5%. The thymoma detection rate was 40.0% among patients with generalized disease, compared with just 7.1% among those with ocular disease.
In a long-term follow-up of patients who initially had only ocular symptoms, 11.2% progressed to generalized disease, with generalized symptoms appearing in most cases within two years of onset. All patients who progressed to generalized disease tested positive for acetylcholine receptor antibodies in blood tests. In addition, 80.0% of patients who progressed had positive repetitive nerve stimulation test results, compared with 20.3% of those who did not progress. Thymoma detection by chest CT also showed a significant association: the rate was 50.0% among patients who progressed to generalized disease, but only 6.3% among those who did not.
The study showed that even when symptoms in patients presenting with diplopia or ptosis are limited to the eyes, blood tests, neurophysiological testing, and chest CT can help identify high-risk patients who require careful follow-up. Since most cases of progression to generalized disease occur within the first two years after onset, patients with risk factors should be closely monitored for the emergence of generalized symptoms during this early period.
Shin Hyun-Jin emphasized, "The course of myasthenia gravis varies from patient to patient. In some cases, symptoms remain confined to the eyes for a long time, while in others, the disease progresses throughout the body relatively early." Shin added, "Even when the disease begins with ocular symptoms, it is important during the early stages to carefully watch for new symptoms, such as weakness in the arms or legs, speech difficulties, trouble swallowing, or breathing discomfort."


[email protected] Medical Specialist Reporter Jeong Myeong-jin Reporter